34 postdoctoral-biomedical-signal-processing Fellowship positions at UNIVERSITY OF SOUTHAMPTON in Uk
-
The Department of Aeronautics and Astronautics at the University of Southampton is welcoming applications for a postdoctoral position in the field of active thermography for the evaluation
-
for a postdoctoral position in the field of active thermography for the evaluation of composite materials and structures. The research will be conducted within the Computational Engineering & Design Group
-
. Experience in Fc glycosylation, effector function studies, or therapeutic antibody development is beneficial. Knowledge of IP processes and translational research is also desirable. Teamwork and Communication
-
, effector functions, or antibody-degrading enzymes. Experience in Fc glycosylation, effector function studies, or therapeutic antibody development is beneficial. Knowledge of IP processes and translational
-
journal publications. The post is based in the Signal Processing, Audio and Hearing (SPAH) Group within the Institute of Sound and Vibration Research (ISVR) in the Faculty of Engineering and Physical
-
of research results through presentations at international conferences and high-quality journal publications. The post is based in the Signal Processing, Audio and Hearing (SPAH) Group within the Institute
-
professional qualification and experience) in biomedical sciences, physiology, reproductive health, or a related discipline, together with laboratory research experience relevant to diagnostic or translational
-
We are seeking a highly motivated Postdoctoral Research Associate in the field of Theoretical and Computational Chemistry to develop accurate models of time-resolved X-ray photoelectron spectroscopy
-
understanding the molecular basis of brain signalling and neurological disorders. Previous experience in tissue culture and proteomics including data collection, processing and interpretation is essential
-
of Southampton. We are seeking a collaborative and motivated postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid